Company: STAA
Filing Date: 2025-12-11
Form Type: DEFA14A
Source: 0001193125-25-315272
Chunk: 2

Company: STAAR SURGICAL CO
Filing Date: 2025-12-11
Form: DEFA14A
Chunk 2
---
,” why wait until so far into the go-shop process to contact STAAR and why were they so slow to respond to STAAR’s proposed NDA? |

| • |     | How did Broadwood know about the process and STAAR’s form of NDA? Is Broadwood working in concert with 
 FountainVest in an effort to derail the process?                                                       |

| • |     | What role did Broadwood play in manufacturing purported interest by Party A, B and C, who did not even request 
 an NDA nor show interest in conducting diligence for a potential acquisition?                                  |

STAAR and its advisors engaged with FountainVest in good faith and encouraged them to execute an NDA, engage with management, and submit an acquisition proposal for the Board’s consideration. Broadwood’s allegation that STAAR “ran the clock” on the go-shopprocess is false and misleading. While the STAAR Board was focused on evaluating all opportunities to maximize value for stockholders, it appears that Broadwood was focused on undermining STAAR’s go-shopprocess.

Stephen Farrell, CEO of STAAR, said, “This is just another example of the misinformation campaign being conducted by Broadwood. This is a pattern, just like Broadwood’s inaccurate characterization of STAAR’s growth rate and its disconnected perspective of market conditions in China.” “We continue to have confidence in our ability to grow the business in the long term, albeit at a significantly lower rate than we enjoyed from 2020 to 2023,” said Mr. Farrell. “However, we have struggled the last few years to grow our procedure volumes in China, and those challenges continue to be a hurdle for STAAR. The softness that we experienced in Q2 and Q3 has continued so far in Q4. Now is the right time to sell, and Alcon has proven to be the right buyer.” STAAR Stockholders Have a Choice Stockholders have a choice - a certain and substantial premium or a multiyear journey starting at a much lower price, led by a misinformed activist who lacks knowledge of this market and has a poor track record of activism. We encourage stockholders to accept Alcon’s increased all-cashoffer of $30.75 per share - a 74% premium to the 90-dayVWAP – representing certain and immediate value. STAAR will hold a virtual Special Meeting of Stockholders on December 19, 2025 at 8:30 a.m. (Pacific Time). Stockholders of record as of the close of business